bioRxivGenomicsPreprint
Systemic mutagen exposures reported by normal kidney cell genomes
Yichen WangiD, W. Knight, Aida Ferreiro-IglesiasiD, Behnoush Abedi‐ArdekaniiD, My H. PhamiD, Sarah MoodyiD, Yvette E. Hooks, Federico AbascaliD, Charles Nunn, Stephen F. FitzgeraldiD, Thomas CattiauxiD, Valérie GaborieauiD, Akihiko FukagawaiD, Viorel JingaiD, Ștefan RașcuiD, Cristian Sima, David Georgievich ZaridzeiD, Anush Mukeria, Ivana HolcátováiD, Anna HorňákováiD, Naveen S. VasudeviD, Rosamonde Elizabeth BanksiD, Simona OgnjanoviciD, Slaviša SavićiD, María Paula CuradoiD, , Michael R. StrattoniD
Abstract
Lifestyle, environmental and other exposures to exogenous mutagens generate somatic mutations in normal human cells in vivo and increase cancer risk. However, the global repertoire of exogenous mutagen exposures is uncertain. The mutational signatures of mutagens in normal tissues offer opportunities to detect such exposures and survey them at population level. Using single-molecule duplex sequencing of normal kidney (n=319) and blood (n=272) samples from 10 countries, we show that normal kidney cell genomes report an extensive repertoire of somatic mutational signatures. Microdissection of kidney structures revealed that proximal tubules exhibit higher mutation rates than other components of the nephron and most normal cell types despite low cell division rates. This is explained by marked enrichment of mutational signatures due to known exogenous carcinogenic mutagens including the plant-derived aristolochic acids, as well as several signatures of unknown causes including an unknown agent prevalent in Japan (SBS12), and signatures of uncertain origins (SBS40b and SBS40c). The results suggest the existence of multiple, common, systemically circulating mutagens affecting human populations and indicate that the genomes of kidney proximal tubule cells report such exposures with high sensitivity.
- organism: human
- assay: whole-genome sequencing
- research focus: variant calling
- approach: statistical model
- Citations
- 1
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A comprehensive atlas of somatic mutation rates and mutational signatures in normal human cells
My H. Pham, Luke M. R. Harvey, … Michael R. Stratton·bioRxiv·Aug 29, 2026
- The Repertoire of Mutational Signatures in Human Cancer
L. Alexandrov, J. Kim, … M. R. Stratton·bioRxiv·Jul 3, 2019
- Defining mutational signatures of lung cancer-associated carcinogens through in vitro exposure of human airway epithelial cells
Natasha Q. Gurevich, Darren Jianjhih Chiu, … Joshua David Campbell·bioRxiv·Mar 9, 2026
- The mutational landscape of human somatic and germline cells
Luiza Moore, Alex Cagan, … Raheleh Rahbari·Yearbook of pediatric endocrinologyPeer-reviewed·Sep 12, 2022
- In-depth characterization of the cisplatin mutational signature in human cell lines and in esophageal and liver tumors
A. Boot, M. N. Huang, … S. G. Rozen·bioRxiv·Dec 17, 2017
- Mutational signatures associated with tobacco smoking in human cancer
Ludmil B Alexandrov, Young Seok Ju, … Michael R Stratton·SciencePeer-reviewed·Nov 4, 2016